2-(4-Chlorophenyl)-4,5-diphenyl-1H-imidazole

Catalog No. :
ACDLHC520
CAS No. :
5496-32-2
Molecular Formula :
C21H15ClN2
Molecular Weight :
330.82

IUPAC Name:2-(4-chlorophenyl)-4,5-diphenyl-1H-imidazole

2-(4-Chlorophenyl)-4,5-diphenyl-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$56.00Login to see priceIn stockIn stock
1g98%$221.00Login to see priceIn stockIn stock
5g98%$947.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chlorophenyl)-4,5-diphenyl-1H-imidazole
IUPAC Name2-(4-chlorophenyl)-4,5-diphenyl-1H-imidazole
MDL No.MFCD09028023
Molecular FormulaC21H15ClN2
Molecular Weight330.82
SMILESClC1=CC=C(C2=NC(C3=CC=CC=C3)=C(C4=CC=CC=C4)N2)C=C1
InChI KeyNJXBHEMXPUMJRO-UHFFFAOYSA-N
SynonymSCHEMBL2127491 | cid_794727 | AKOS000583511 | CS-0181803 | 2-(4-Chlorophenyl)-4,5-diphenyl-1H-imidazole;2-(4-Chlorophenyl)-4,5-diphenylimidazole | MFCD00030329 | 2-(4-chlorophenyl)-4,5-diphenylimidazole | C2990 | 2-(2-Chlorophenyl)-4,5-diphenylimidazole-1
CAS No.5496-32-2
PubChem CID794727

Safety Data

Pictogram
Environmental hazard
Signal Word
Achtung
Hazard Statement(s)
H410
Precautionary Statement(s)
P273-P501

Synthetic Route by SureRoute

1. ACDLHC520 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPAME401 route compound structure diagram
    ACPAME401134-81-6 In Stock
  4. Then
  5. ACDLHC520 route product structure diagram
    ACDLHC5205496-32-2 In Stock
Inquiry

2. ACDLHC520 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACESVR048 route compound structure diagram
    ACESVR04814401-51-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDLHC520 route product structure diagram
    ACDLHC5205496-32-2 In Stock
Inquiry

Comments (0)